Japanese Healthtech Startup Quadlytics Raises ¥600 Million Series B

On 4 November, Kyoto-based Quadlytics raised ¥600 million through a Series B financing round to develop wearable technology and software designed to identify warning signs before epileptic seizures. The funding will support research, clinical development and international expansion. HPC can support healthcare market research, technology partnerships and medical-sector investment analysis.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.